Bruker Corporation (BRKR) Stock Forecast
BRKR analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.69 / 5 from 13 analysts
- Price target
- $63.83 average of analyst targets
- Upside to target
- +16.5% from the latest close
- Next earnings
- November 2, 2026 EPS estimate $0.42
- 52-week range
- $32.76 – $64.75
BRKR analyst ratings
13 analystsNumber of analysts at each rating.
BRKR price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
BRKR earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.42 | $0.39 | $0.45 | $0.45 | −7.5% | 12 |
| Current fiscal year (2026) | $2.12 | $2.10 | $2.14 | $1.83 | +15.8% | 13 |
| Next fiscal year (2027) | $2.40 | $2.28 | $2.47 | $2.12 | +13.4% | 13 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
BRKR revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $865.2M | $849.2M | $871.0M | +0.5% | 11 |
| Current fiscal year (2026) | $3.56B | $3.55B | $3.57B | +3.5% | 12 |
| Next fiscal year (2027) | $3.70B | $3.66B | $3.76B | +4.2% | 12 |
BRKR EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
BRKR revenue: reported and forecast
BRKR EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.55 | $0.42 | $0.42 | $0.42 | $0.42 | −24.5% | 1 up · 1 down |
| Current fiscal year (2026) | $2.12 | $2.12 | $2.12 | $2.12 | $2.12 | +0.0% | 0 up · 2 down |
| Next fiscal year (2027) | $2.43 | $2.41 | $2.39 | $2.41 | $2.40 | −1.1% | 3 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
BRKR earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; BRKR beat in 10 of 12.
What analysts expect from BRKR
13 analysts cover Bruker; their consensus rating is buy (3.69 on a 1–5 scale, where 5 is a strong buy). The average price target is $63.83, 16.5% above the latest close of $54.80. Analysts expect earnings of $2.12 per share for 2026, +15.8% from a year earlier. For 2027 the average estimate is $2.40 per share on revenue of $3.7 billion. Bruker beat the EPS estimate in 10 of the last 12 quarters.
Related: BRKR income statement, BRKR key metrics, BRKR chart. See the BRKR stock overview for the latest quote and news.
BRKR forecast FAQ
What is Bruker's price target?
The average analyst price target for Bruker is $63.83, 16.5% above the latest close of $54.80.
Is Bruker a buy, hold or sell?
Of 13 analysts covering Bruker, 5 rate it a strong buy, 1 a buy, 6 a hold, 0 a sell and 1 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Bruker's EPS forecast?
Analysts forecast $2.12 per share for 2026 (range $2.10 to $2.14); for 2027 the estimate is $2.40.
What is Bruker's revenue forecast?
The average revenue estimate for 2026 is $3.6 billion, growth of 3.5%; for 2027 it is $3.7 billion.
When does Bruker report earnings?
Bruker is expected to report results for the quarter ending September 30, 2026 on November 2, 2026; the EPS estimate is $0.42.
Does Bruker usually beat earnings estimates?
Bruker reported EPS at or above the analyst estimate in 10 of the last 12 quarters.